title: Optimisation and in vivo evaluation of pectin based drug delivery system containing curcumin for colon.
abstract: The higher incidences of side effects of existing drugs have shifted researchers and clinicians to explore the dietary phytoconstituents for its therapeutic potentials. The present study is based on compression coated curcumin tablet for the colon. Curcumin has anti-inflammatory and antioxidant properties. Curcumin presents a bioavailability problem due to poor solubility. An inclusion complex was formed with hydroxypropyl-β-cyclodextrin to enhance the solubility. In this study, the core tablet of curcumin inclusion complex was compressed between the layers of polymer blend of pectin and Eudragit S100. The 3(2) full factorial design was utilised for optimization of the formulation. The polymer ratio (X1) and coat thickness (X2) presented significant effects on the selected responses, i.e., percent drug release after 4 hours (Y240) and difference in percent drug release between 4th and 6th hour (Y diff) in presence of pectinase enzyme. The results revealed that higher coat weight (600 mg) and higher level of pectin ratio (70% w/w) protected the curcumin tablet till ascending colon. The in vivo studies by roentgenography method using human volunteers supported these observations. Hence, it can be concluded that the combination of pectin and Eudrgit S100 makes the system biodegradable and pH dependent for targeting the drug to the colon.
authors.affiliation: Department of Pharmaceutics, Oriental College of Pharmacy, Sector 2, Sanpada, Navi Mumbai 400 705, India.
authors.forename: Kishor
authors.identifier: 0000-0002-3474-3772
authors.initials: K
authors.lastname: Butte
authors.affiliation: Department of Pharmaceutics, Oriental College of Pharmacy, Sector 2, Sanpada, Navi Mumbai 400 705, India.
authors.forename: Munira
authors.initials: M
authors.lastname: Momin
authors.affiliation: Department of Radiology, Seth GS Medical College and KEM Hospital, Mumbai 400 012, India.
authors.forename: Hemant
authors.initials: H
authors.lastname: Deshmukh
references.citation: J Pharm Sci. 1965 May;54(5):747-52
references.pmid: 5845889
references.citation: J Pharm Pharm Sci. 2003 Jan-Apr;6(1):33-66
references.pmid: 12753729
references.citation: J Pharm Pharm Sci. 2004 Sep 24;7(3):325-31
references.pmid: 15576012
references.citation: Drug Dev Ind Pharm. 2003 Apr;29(4):375-86
references.pmid: 12737531
references.citation: J Control Release. 2003 Feb 14;88(1):95-103
references.pmid: 12586507
references.citation: J Pharm Pharmacol. 2005 Feb;57(2):163-8
references.pmid: 15720778
references.citation: J Drug Target. 2009 Apr;17(3):235-41
references.pmid: 19558362
references.citation: J Control Release. 1999 Apr 19;58(3):303-10
references.pmid: 10099155